サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1720750

胆汁性そう痒症の世界市場レポート 2025年

Cholestatic Pruritus Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
胆汁性そう痒症の世界市場レポート 2025年
出版日: 2025年05月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

胆汁性そう痒症市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.3％で、249億7,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、アトピー性皮膚炎や蕁麻疹の有病率の増加、慢性腎臓病の罹患率の増加、そう痒症に関連する疾患の有病率の増加に起因すると考えられます。この期間の主な動向としては、新たな治療オプションの導入、胆汁性そう痒症研究のための大手企業との提携、治療方法の革新、ヘルスケア施設の拡大、治療技術の進歩などが挙げられます。

肝疾患の有病率の増加は、胆汁性そう痒症市場の成長を促進すると予想されています。肝疾患には、感染症、自己免疫疾患、遺伝的疾患、毒素による損傷など、肝機能を損なう幅広い疾患が含まれ、これらすべてが炎症や瘢痕化、さらには肝不全につながる可能性があります。肥満率の上昇、糖尿病、飲酒、ウイルス性肝炎、環境毒素への暴露などの要因が、肝疾患の有病率の上昇に寄与しています。胆汁性そう痒症は、胆汁の流れが悪くなっていることを示し、しばしば肝臓の基礎疾患のさらなる調査や治療を促すため、肝臓疾患を特定し管理するための重要な症状です。例えば、2023年7月、健康格差の是正に重点を置く英国政府機関であるOffice for Health Improvement and Disparitiesは、イングランドにおける肝疾患による入院患者数が2022年までの1年間で67,458人から82,290人へと22％増加したと報告しました。このように、肝疾患の罹患率の増加は、胆汁性そう痒症市場における治療需要の原動力となると思われます。

胆汁性そう痒症市場の主要企業は、症状をよりよく管理し、患者のコンプライアンスを向上させ、胆汁酸塩の蓄積や炎症の根本原因に対処することで的を絞った緩和を提供するために、経口ソリューションなどの革新的な治療法の開発に注力しています。胆汁性そう痒症の経口剤は、胆汁酸の蓄積を抑え、胆汁うっ滞患者のひどいかゆみを緩和するように設計された液体薬です。例えば、2024年3月、米国を拠点とするバイオ医薬品会社であるMirum Pharmaceuticals Inc.は、5歳以上の進行性家族性肝内胆汁うっ滞（PFIC）患者の胆汁性そう痒症治療に使用されるLIVMARLI（maralixibat）経口液の承認を米国食品医薬品局（FDA）から取得しました。本剤は1日1回経口投与の回腸型胆汁酸トランスポーター阻害剤であり、PFIC2型の画期的治療薬に指定されています。LIVMARLIは、PFICに関連する胆汁性そう痒症を持つ患者、特に最も稀なサブタイプを持つ患者にとって、切望されていた治療選択肢を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界胆汁性そう痒症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の胆汁性そう痒症市場：成長率分析
  • 世界の胆汁性そう痒症市場の実績：規模と成長, 2019-2024
  • 世界の胆汁性そう痒症市場の予測：規模と成長, 2024-2029, 2034F
  • 世界胆汁性そう痒症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の胆汁性そう痒症市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 原発性胆汁性胆管炎（PBC）
  • 原発性硬化性胆管炎（PSC）
  • 妊娠性肝内胆汁うっ滞（ICP）
  • その他の病気の種類
  • 世界の胆汁性そう痒症市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 医薬品
  • 光線療法
  • その他の治療の種類
  • 世界の胆汁性そう痒症市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • トピック
  • 注射剤
  • 世界の胆汁性そう痒症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • クリニック
  • 外来診療センター
  • ホームケア
  • 世界の胆汁性そう痒症市場原発性胆汁性胆管炎（PBC）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 初期段階のPBC
  • 高度なPBC
  • 肝硬変を伴うPBC
  • 肝不全を伴うPBC
  • 世界の胆汁性そう痒症市場原発性硬化性胆管炎（PSC）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • クラシックPSC
  • 潰瘍性大腸炎を伴うPSC
  • 胆管狭窄を伴うPSC
  • 世界の胆汁性そう痒症市場妊娠性肝内胆汁うっ滞（ICP）の病型別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 軽度の頭蓋内圧亢進症
  • 重度の頭蓋内圧亢進症
  • 早産リスクを伴うICP
  • 世界の胆汁性そう痒症市場、その他の疾患タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アルコール性胆汁うっ滞
  • 薬剤性胆汁うっ滞
  • ウイルス性肝炎誘発性胆汁うっ滞
  • 遺伝性胆汁うっ滞疾患

第7章 地域別・国別分析

  • 世界の胆汁性そう痒症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の胆汁性そう痒症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 胆汁性そう痒症市場：競合情勢
  • 胆汁性そう痒症市場：企業プロファイル
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Incyte Corporation
  • Ipsen Pharma
  • Vanda Pharmaceuticals Inc.
  • Medison Pharma Ltd.
  • Mirum Pharmaceuticals Inc.
  • Albireo Pharma Inc.
  • Dipharma Francis S.r.l.
  • Cara Therapeutics Inc.
  • CANbridge Pharmaceuticals Inc.
  • Escient Pharmaceuticals Inc.
  • Tharimmune Inc.
  • Vifor Fresenius Medical Care Renal Pharma
  • CymaBay Therapeutics Inc.
  • ICE Pharma Inc.
  • Aquatic Remedies Private Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 胆汁性そう痒症市場2029：新たな機会を提供する国
  • 胆汁性そう痒症市場2029：新たな機会を提供するセグメント
  • 胆汁性そう痒症市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r34006

Cholestatic pruritus is a condition characterized by severe itching due to the accumulation of bile acids in the skin, often caused by liver diseases that hinder bile flow. This condition can greatly impact a patient's quality of life and typically requires targeted treatments to alleviate discomfort and address the underlying liver dysfunction.

The primary disease types associated with cholestatic pruritus include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP), and other related conditions. Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that progressively destroys the bile ducts, causing bile accumulation, liver damage, and possibly cirrhosis. Treatment options for cholestatic pruritus include medications, phototherapy, and other treatments, with administration routes such as oral, topical, and injectable forms. The key end-users for these treatments include hospitals, clinics, ambulatory care centers, and home care settings.

The cholestatic pruritus market research report is one of a series of new reports from The Business Research Company that provides cholestatic pruritus market statistics, including the cholestatic pruritus industry global market size, regional shares, competitors with the cholestatic pruritus market share, detailed cholestatic pruritus market segments, market trends, and opportunities, and any further data you may need to thrive in the cholestatic pruritus industry. This cholestatic pruritus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cholestatic pruritus market size has grown strongly in recent years. It will grow from $19.20 billion in 2024 to $20.28 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing prevalence of skin disorders, higher investments in research and development, growing demand for effective treatments, greater awareness of the condition, and favorable regulatory environments.

The cholestatic pruritus market size is expected to see strong growth in the next few years. It will grow to $24.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the rising elderly population, the increasing prevalence of atopic dermatitis and urticaria, a higher incidence of chronic kidney diseases, and the growing prevalence of conditions associated with pruritus. Key trends during this period include the introduction of new treatment options, partnerships with major companies for cholestatic pruritus research, innovations in treatment modalities, the expansion of healthcare facilities, and technological advancements in care.

The increasing prevalence of liver diseases is expected to drive the growth of the cholestatic pruritus market. Liver diseases encompass a wide range of conditions that impair liver function, including infections, autoimmune disorders, genetic conditions, and damage from toxins, all of which can lead to inflammation, scarring, or even liver failure. Factors such as rising obesity rates, diabetes, alcohol consumption, viral hepatitis, and exposure to environmental toxins contribute to the growing prevalence of liver diseases. Cholestatic pruritus is an important symptom for identifying and managing liver diseases, as it signals impaired bile flow and often prompts further investigation and treatment of underlying liver conditions. For example, in July 2023, the Office for Health Improvement and Disparities, a UK government agency focused on reducing health inequalities, reported that hospital admissions for liver disease in England had risen by 22% in the year ending 2022, from 67,458 to 82,290. The increasing incidence of liver diseases will thus drive the demand for treatments in the cholestatic pruritus market.

Major companies in the cholestatic pruritus market are focusing on developing innovative treatments, such as oral solutions, to better manage symptoms, improve patient compliance, and provide targeted relief by addressing the root causes of bile salt buildup and inflammation. Oral solutions for cholestatic pruritus are liquid medications designed to reduce bile acid accumulation and alleviate severe itching in patients with cholestasis. For instance, in March 2024, Mirum Pharmaceuticals Inc., a U.S.-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for LIVMARLI (maralixibat) oral solution, which is used to treat cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered medication is an ileal bile acid transporter inhibitor and has been designated as a breakthrough therapy for PFIC type 2. LIVMARLI offers a much-needed treatment option for patients with cholestatic pruritus linked to PFIC, particularly for those with the rarest subtypes.

In September 2023, Travere Therapeutics Inc., a U.S.-based biopharmaceutical company, entered into a partnership with Mirum Pharmaceuticals Inc. Through this collaboration, Travere will focus on its core therapeutic areas while Mirum continues to expand its portfolio and develop and commercialize bile acid therapies for rare liver diseases. Mirum Pharmaceuticals is dedicated to advancing treatments for rare liver diseases, including those associated with cholestatic pruritus.

Major players in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., and Aquatic Remedies Private Limited.

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cholestatic pruritus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cholestatic pruritus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cholestatic pruritus market consists of revenues earned by entities by providing services such as diagnosis and screening services, medical consultations and treatment management, patient support programs, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of ursodeoxycholic acid, topical corticosteroids, and opioid antagonists. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cholestatic Pruritus Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cholestatic pruritus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cholestatic pruritus ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cholestatic pruritus market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types
  • 2) By Treatment Type: Medications; Phototherapy; Other Treatment Types
  • 3) By Route Of Administration: Oral; Topical; Injectable
  • 4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare
  • Subsegments:
  • 1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure
  • 2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures
  • 3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk
  • 4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders
  • Companies Mentioned: GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Merck KGaA; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cholestatic Pruritus Market Characteristics

3. Cholestatic Pruritus Market Trends And Strategies

4. Cholestatic Pruritus Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cholestatic Pruritus Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cholestatic Pruritus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cholestatic Pruritus Market Growth Rate Analysis
  • 5.4. Global Cholestatic Pruritus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cholestatic Pruritus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cholestatic Pruritus Total Addressable Market (TAM)

6. Cholestatic Pruritus Market Segmentation

  • 6.1. Global Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Biliary Cholangitis (PBC)
  • Primary Sclerosing Cholangitis (PSC)
  • Intrahepatic Cholestasis of Pregnancy (ICP)
  • Other Disease Types
  • 6.2. Global Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medications
  • Phototherapy
  • Other Treatment Types
  • 6.3. Global Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Topical
  • Injectable
  • 6.4. Global Cholestatic Pruritus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Homecare
  • 6.5. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Biliary Cholangitis (PBC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Early-Stage PBC
  • Advanced PBC
  • PBC With Cirrhosis
  • PBC With Liver Failure
  • 6.6. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Sclerosing Cholangitis (PSC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Classic PSC
  • PSC With Ulcerative Colitis
  • PSC With Bile Duct Strictures
  • 6.7. Global Cholestatic Pruritus Market, Sub-Segmentation Of Intrahepatic Cholestasis of Pregnancy (ICP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mild ICP
  • Severe ICP
  • ICP With Preterm Birth Risk
  • 6.8. Global Cholestatic Pruritus Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alcoholic Cholestasis
  • Drug-Induced Cholestasis
  • Viral Hepatitis-Induced Cholestasis
  • Genetic Cholestasis Disorders

7. Cholestatic Pruritus Market Regional And Country Analysis

  • 7.1. Global Cholestatic Pruritus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cholestatic Pruritus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cholestatic Pruritus Market

  • 8.1. Asia-Pacific Cholestatic Pruritus Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cholestatic Pruritus Market

  • 9.1. China Cholestatic Pruritus Market Overview
  • 9.2. China Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cholestatic Pruritus Market

  • 10.1. India Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cholestatic Pruritus Market

  • 11.1. Japan Cholestatic Pruritus Market Overview
  • 11.2. Japan Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cholestatic Pruritus Market

  • 12.1. Australia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cholestatic Pruritus Market

  • 13.1. Indonesia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cholestatic Pruritus Market

  • 14.1. South Korea Cholestatic Pruritus Market Overview
  • 14.2. South Korea Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cholestatic Pruritus Market

  • 15.1. Western Europe Cholestatic Pruritus Market Overview
  • 15.2. Western Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cholestatic Pruritus Market

  • 16.1. UK Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cholestatic Pruritus Market

  • 17.1. Germany Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cholestatic Pruritus Market

  • 18.1. France Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cholestatic Pruritus Market

  • 19.1. Italy Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cholestatic Pruritus Market

  • 20.1. Spain Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cholestatic Pruritus Market

  • 21.1. Eastern Europe Cholestatic Pruritus Market Overview
  • 21.2. Eastern Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cholestatic Pruritus Market

  • 22.1. Russia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cholestatic Pruritus Market

  • 23.1. North America Cholestatic Pruritus Market Overview
  • 23.2. North America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cholestatic Pruritus Market

  • 24.1. USA Cholestatic Pruritus Market Overview
  • 24.2. USA Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cholestatic Pruritus Market

  • 25.1. Canada Cholestatic Pruritus Market Overview
  • 25.2. Canada Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cholestatic Pruritus Market

  • 26.1. South America Cholestatic Pruritus Market Overview
  • 26.2. South America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cholestatic Pruritus Market

  • 27.1. Brazil Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cholestatic Pruritus Market

  • 28.1. Middle East Cholestatic Pruritus Market Overview
  • 28.2. Middle East Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cholestatic Pruritus Market

  • 29.1. Africa Cholestatic Pruritus Market Overview
  • 29.2. Africa Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cholestatic Pruritus Market Competitive Landscape And Company Profiles

  • 30.1. Cholestatic Pruritus Market Competitive Landscape
  • 30.2. Cholestatic Pruritus Market Company Profiles
    • 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cholestatic Pruritus Market Other Major And Innovative Companies

  • 31.1. Incyte Corporation
  • 31.2. Ipsen Pharma
  • 31.3. Vanda Pharmaceuticals Inc.
  • 31.4. Medison Pharma Ltd.
  • 31.5. Mirum Pharmaceuticals Inc.
  • 31.6. Albireo Pharma Inc.
  • 31.7. Dipharma Francis S.r.l.
  • 31.8. Cara Therapeutics Inc.
  • 31.9. CANbridge Pharmaceuticals Inc.
  • 31.10. Escient Pharmaceuticals Inc.
  • 31.11. Tharimmune Inc.
  • 31.12. Vifor Fresenius Medical Care Renal Pharma
  • 31.13. CymaBay Therapeutics Inc.
  • 31.14. ICE Pharma Inc.
  • 31.15. Aquatic Remedies Private Limited

32. Global Cholestatic Pruritus Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cholestatic Pruritus Market

34. Recent Developments In The Cholestatic Pruritus Market

35. Cholestatic Pruritus Market High Potential Countries, Segments and Strategies

  • 35.1 Cholestatic Pruritus Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cholestatic Pruritus Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cholestatic Pruritus Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer